BioSyntech Grants Stock Options.LAVAL, Canada -- In accordance with its continuous disclosure obligations, BioSyntech, Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension VENTURE:BSY BSY Busy BSY British School of Yoga BSY Bit Sync BSY Busy Line ) announces the grant of options to acquire 15,000 common shares of its capital stock at a price of $0.69 per share for a period of five years to each of its four independent directors, namely: Mr. Joseph Benarrosh, Mr. Christophe Guy, Mr. Somesh Sharma and Mr. Serge Savard Serge Aubrey Savard, OC (born January 22, 1946 in Montreal, Quebec) is a former professional ice hockey defenceman, most famously with the Montreal Canadiens in the NHL. He is also a local businessman in Montreal, and is nicknamed the Senator. . Furthermore, Mr. Joseph Benarrosh has been granted options to acquire 15,000 additional shares on the same terms and conditions in his capacity as Chairman of the Company's Audit Committee. BioSyntech further announces that it has renewed options to acquire an aggregate number of 590,000 common shares which had recently expired. All of these options were renewed for an additional period of five years at an exercise price of $0.69 per share. Included in the renewed options are options to acquire an aggregate of 185,000 shares held by directors and officers, namely: Mr. Serge Savard (50,000), Mr. Christophe Guy (15,000), Mr. Eric Desrosiers (30,000), Mrs. Lucie Duval (60,000) and Mr. Matthew Shive n. 1. A slice; as, a shive of bread s>. 2. A thin piece or fragment; specifically, one of the scales or pieces of the woody part of flax removed by the operation of breaking. 3. (30,000). BioSyntech currently has an aggregate of 4,651,000 options issued and outstanding, representing approximately 11% of its issued and outstanding common shares. About BioSyntech BioSyntech is a biotechnology company specializing in the discovery, development and manufacturing of innovative cost-effective and physician-friendly biotherapeutic thermogels for regenerative medicine and therapeutic delivery. BioSyntech's Quality Management System is registered to ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 standards. For additional information, visit www.biosyntech.com. NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE TSX VENTURE EXCHANGE TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. BioSyntech Inc. (TSX VENTURE:BSY) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion